Semenogelin I (SEMG1) (Middle Region) Peptide
SEMG1
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN983528
Quick Overview for Semenogelin I (SEMG1) (Middle Region) Peptide (ABIN983528)
Target
SEMG1
(Semenogelin I (SEMG1))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-SEMG1 antibody (Catalog #: ARP42089_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- SEMG1 (Semenogelin I (SEMG1))
-
Background
-
SEMG1 is the predominant protein in semen. The secreted protein is involved in the formation of a gel matrix that encases ejaculated spermatozoa. The prostate-specific antigen (PSA) protease processes this protein into smaller peptides, with each possibly
Alias Symbols: MGC14719, SEMG, SGI, CT103, dJ172H20.2
Protein Interaction Partner: KLK2,KLK3,PRKCA,SEMG2,TGM1,UBQLN4,SEMG2
Protein Size: 402 -
Molecular Weight
- 40 kDa
-
Gene ID
- 6406
-
NCBI Accession
- NM_198139, NP_937782
Target
-
You are here:
